Mirjam Blattner

Characterizing and explaining the impact of disease-associated mutations in proteins without known structures or structural homologs

Engineering precision nanoparticles for drug delivery

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments

Cell cycle proteins as promising targets in cancer therapy

Considerations and Challenges in Studying Liquid-Liquid Phase Separation and Biomolecular Condensates

Inflammation and tumor progression: signaling pathways and targeted intervention

Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing

Prostate Cancer

Comprehensive assessment of cancer missense mutation clustering in protein structures

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Metastatic Prostate Cancer

Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer

Evidence for Molecular Differences in Prostate Cancer between African American and Caucasian Men

SPOP mutation leads to genomic instability in prostate cancer

Inherited determinants of early recurrent somatic mutations in prostate cancer

SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling

Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover